Cirrhosis, Age, and Liver Stiffness-Based Models Predict Hepatocellular Carcinoma in Asian Patients with Chronic Hepatitis B

被引:5
作者
Lim, Jihye [1 ]
Chon, Young Eun [2 ]
Kim, Mi Na [2 ]
Lee, Joo Ho [2 ]
Hwang, Seong Gyu [2 ]
Lee, Han Chu [1 ]
Ha, Yeonjung [2 ]
机构
[1] Univ Ulsan, Asan Liver Ctr, Asan Med Ctr, Coll Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
[2] CHA Univ, Dept Gastroenterol, CHA Bundang Med Ctr, 59 Yatap Ro, Seongnam Si 13496, Gyeonggi Do, South Korea
关键词
validation; prediction; CAGE-B; SAGE-B; hepatocellular carcinoma; GENOTYPE-C; RISK; DIAGNOSIS; THERAPY;
D O I
10.3390/cancers13225609
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple SummaryPredicting hepatocellular carcinoma in patients with chronic hepatitis B who receive long-term treatment with entecavir or tenofovir is of particular importance in terms of the allocation of medical resources for cancer surveillance. The Cirrhosis and Age (CAGE-B) and Stiffness and Age (SAGE-B) scores were developed to predict hepatocellular carcinoma in Caucasian patients receiving long-term entecavir or tenofovir therapy. In Asian patients who were treated with entecavir or tenofovir, the CAGE-B score predicted the incidence of hepatocellular carcinoma with acceptable accuracy, regardless of the treatment regimen, sex, or hepatic steatosis. Existing prediction models, which showed predictive ability comparable to that of the CAGE-B score, could be used in resource-limited settings where transient elastography is unavailable.Objectives: Predicting hepatocellular carcinoma (HCC) in patients with chronic hepatitis B who received long-term therapy with potent nucleos(t)ide analogs is of utmost importance to refine the strategy for HCC surveillance. Methods: We conducted a multicenter retrospective cohort study to validate the CAGE-B and SAGE-B scores, HCC prediction models developed for Caucasian patients receiving entecavir (ETV) or tenofovir (TFV) for > 5 years. Consecutive patients who started ETV or TFV at two hospitals in Korea from January 2009 to December 2015 were identified. The prediction scores were calculated, and model performance was assessed using receiver operating characteristics (ROC) curves. Results: Among 1557 patients included, 57 (3.7%) patients had HCC during a median follow-up of 93 (95% confidence interval, 73-119) months. In the entire cohort, CAGE-B predicted HCC with an area under the ROC curve of 0.78 (95% CI, 0.72-0.84). Models that have "liver cirrhosis " in the calculation, such as AASL (0.79 (0.72-0.85)), CU-HCC (0.77 (0.72-0.82)), and GAG-HCC (0.79 (0.74-0.85)), showed accuracy similar to that of CAGE-B (p > 0.05); however, models without "liver cirrhosis ", including SAGE-B (0.71 (0.65-0.78)), showed a lower predictive ability than CAGE-B. CAGE-B performed well in subgroups of patients treated without treatment modification (0.81 (0.73-0.88)) and of male sex (0.79 (0.71-0.86)). Conclusions: This study validated the clinical usefulness of the CAGE-B score in a large number of Asian patients treated with long-term ETV or TFV. The results could provide the basis for the reappraisal of HCC surveillance strategies and encourage future prospective validation studies with liver stiffness measurements.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis
    Liu, Ken
    Choi, Jonggi
    Le, An
    Yip, Terry Cheuk-Fung
    Wong, Vincent Wai-Sun
    Chan, Stephen Lam
    Chan, Henry Lik-Yuen
    Nguyen, Mindie H.
    Lim, Young-Suk
    Wong, Grace Lai-Hung
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (09) : 1037 - 1048
  • [42] Prediction of liver stiffness hepatocellular carcinoma in chronic hepatitis C patients on interferon-based anti-viral therapy
    Narita, Yutaka
    Genda, Takuya
    Tsuzura, Hironori
    Sato, Shunsuke
    Kanemitsu, Yoshio
    Ishikawa, Sachiko
    Kikuchi, Tetsu
    Hirano, Katsuharu
    Iijima, Katsuyori
    Wada, Ryo
    Ichida, Takafumi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (01) : 137 - 143
  • [43] Hepatocellular Carcinoma Incidence in Noncirrhotic Patients With Chronic Hepatitis B and Patients With Cirrhosis of All Etiologies
    Do, Ailinh L.
    Wong, Carrie R.
    Nguyen, Long H.
    Nguyen, Vincent G.
    Huy Trinh
    Nguyen, Mindie H.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2014, 48 (07) : 644 - 649
  • [44] Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patients
    Matt Liu
    Tai-Chung Tseng
    Dae Won Jun
    Ming-Lun Yeh
    Huy Trinh
    Grace L. H. Wong
    Chien-Hung Chen
    Cheng-Yuan Peng
    Sung Eun Kim
    Hyunwoo Oh
    Min-Sun Kwak
    Michael Cheung
    Hidenori Toyoda
    Yao-Chun Hsu
    Jae Yoon Jeong
    Eileen L. Yoon
    Teerapat Ungtrakul
    Jian Zhang
    Qing Xie
    Sang Bong Ahn
    Masaru Enomoto
    Jae-Jun Shim
    Chris Cunningham
    Soung Won Jeong
    Yong Kyun Cho
    Eiichi Ogawa
    Rui Huang
    Dong-Hyun Lee
    Hirokazu Takahashi
    Pei-Chien Tsai
    Chung-Feng Huang
    Chia-Yen Dai
    Cheng-Hao Tseng
    Satoshi Yasuda
    Ritsuzo Kozuka
    Jiayi Li
    Christopher Wong
    Clifford C. Wong
    Changqing Zhao
    Joseph Hoang
    Yuichiro Eguchi
    Chao Wu
    Yasuhito Tanaka
    Ed Gane
    Tawesak Tanwandee
    Ramsey Cheung
    Man-Fung Yuen
    Hyo-Suk Lee
    Ming-Lung Yu
    Jia-Horng Kao
    Hepatology International, 2021, 15 : 71 - 81
  • [45] Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patients
    Liu, Matt
    Tseng, Tai-Chung
    Jun, Dae Won
    Yeh, Ming-Lun
    Huy Trinh
    Wong, Grace L. H.
    Chen, Chien-Hung
    Peng, Cheng-Yuan
    Kim, Sung Eun
    Oh, Hyunwoo
    Kwak, Min-Sun
    Cheung, Michael
    Toyoda, Hidenori
    Hsu, Yao-Chun
    Jeong, Jae Yoon
    Yoon, Eileen L.
    Ungtrakul, Teerapat
    Zhang, Jian
    Xie, Qing
    Ahn, Sang Bong
    Enomoto, Masaru
    Shim, Jae-Jun
    Cunningham, Chris
    Jeong, Soung Won
    Cho, Yong Kyun
    Ogawa, Eiichi
    Huang, Rui
    Lee, Dong-Hyun
    Takahashi, Hirokazu
    Tsai, Pei-Chien
    Huang, Chung-Feng
    Dai, Chia-Yen
    Tseng, Cheng-Hao
    Yasuda, Satoshi
    Kozuka, Ritsuzo
    Li, Jiayi
    Wong, Christopher
    Wong, Clifford C.
    Zhao, Changqing
    Hoang, Joseph
    Eguchi, Yuichiro
    Wu, Chao
    Tanaka, Yasuhito
    Gane, Ed
    Tanwandee, Tawesak
    Cheung, Ramsey
    Yuen, Man-Fung
    Lee, Hyo-Suk
    Yu, Ming-Lung
    Kao, Jia-Horng
    HEPATOLOGY INTERNATIONAL, 2021, 15 (01) : 71 - 81
  • [46] HBcrAg Predicts Hepatocellular Carcinoma Development in Chronic B Hepatitis Related Liver Cirrhosis Patients Undergoing Long-Term Effective Anti-Viral
    Chang, Kuo-Chin
    Lin, Ming-Tsung
    Wang, Jing-Houng
    Hung, Chao-Hung
    Chen, Chien-Hung
    Chiu, Sherry Yueh-Hsia
    Hu, Tsung-Hui
    VIRUSES-BASEL, 2022, 14 (12):
  • [47] Thyroid hormone, immunoglobin and complements for predicting hepatocellular carcinoma development in patients with hepatitis B virus-related liver cirrhosis
    Tong, Xue-Cheng
    Liu, Kai
    Huang, Ze-Yu
    Zhang, Xiu-Jun
    Xue, Yuan
    WORLD JOURNAL OF HEPATOLOGY, 2025, 17 (02) : 1 - 10
  • [48] Liver stiffness measurement in patients with cirrhosis and hepatocellular carcinoma: a case-control study
    Nahon, Pierre
    Kettaneh, Adrien
    Lemoine, Maud
    Seror, Olivier
    Barget, Nathalie
    Trinchet, Jean-Claude
    Beaugrand, Michel
    Ganne-Carrie, Nathalie
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (02) : 214 - 219
  • [49] Association analysis of KIR/HLA genotype with liver cirrhosis, hepatocellular carcinoma, and NUC freedom in chronic hepatitis B patients
    Joshita, Satoru
    Ota, Masao
    Kobayashi, Hiroyuki
    Wakabayashi, Shun-ichi
    Yamashita, Yuki
    Sugiura, Ayumi
    Yamazaki, Tomoo
    Tanaka, Eiji
    Umemura, Takeji
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [50] Prediction of chronic hepatitis B, liver cirrhosis and hepatocellular carcinoma by SELDI-based serum decision tree classification
    Cui, Jiefeng
    Kang, Xiaonan
    Dai, Zhi
    Huang, Cheng
    Zhou, Haijun
    Guo, Kun
    Li, Yan
    Zhang, Yu
    Sun, Ruixia
    Chen, Jie
    Li, Yang
    Tang, Zhaoyou
    Uemura, Toshimasa
    Liu, Yinkun
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2007, 133 (11) : 825 - 834